🔎 Trials Near Me

Home › Metastatic Cancer › NCT06165419

Definitive Radiation for High-Risk Spine Metastases

RecruitingPhase 2

A Phase II Study Evaluating Definitive Radiosurgical Decompression in Patients With High-Risk Spinal Metastases

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Eligible patients must have:

* Any pathologically proven solid tumor diagnosis not of central nervous system origin with radiographic or pathologic evidence of metastatic disease
* Metastatic spine involvement documented by imaging
* Involvement of maximum 3 contiguous vertebral bodies at the index site
* Intact neurologic function, or only minor neurologic deficits with muscle strength greater or equal to 4 out of 5 with or without steroids
* An evaluation by an radiation oncology and orthopedic spine/neurosurgery attending
* ECOG Performance Status of 0-3

Patients are ineligible if they have:

* An unstable spine defined as a Spinal Instability Neoplastic Score (SINS) greater than 12
* Had previous surgery or radiation to address the target spinal metastases
* Radiosensitive tumors (e.g. small cell lung cancer, lymphoma, multiple myeloma, and germ-cell tumors)

About the study

This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only and avoid a large spine surgery

What is being tested

Sponsor: Stony Brook University · Participants: 26 · Started: Dec 14, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT06165419

Locations in the U.S.

New YorkStony Brook University Hospital, Stony Brook

Conditions

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.